The UK has just introduced the world’s first national programme offering a vaccine to help protect against gonorrhoea. This coincides with increasing rates of sexually transmitted infections (STIs) including antibiotic-resistant strains of Neisseria gonorrhoeae, particularly among gay, bisexual and other men who have sex with men.
The vaccine being offered was not originally designed for gonorrhoea. It is the meningococcal B (MenB) vaccine, developed to protect against Neisseria meningitidis – the bacteria which cause meningitis.
